↓ Skip to main content

The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy

Overview of attention for article published in Europace, October 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

policy
2 policy sources
patent
1 patent

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
88 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy
Published in
Europace, October 2014
DOI 10.1093/europace/euu188
Pubmed ID
Authors

Mattias Aronsson, Håkan Walfridsson, Magnus Janzon, Ulla Walfridsson, Jens Cosedis Nielsen, Peter Steen Hansen, Arne Johannessen, Pekka Raatikainen, Gerhard Hindricks, Ole Kongstad, Steen Pehrson, Anders Englund, Juha Hartikainen, Leif Spange Mortensen, Lars-Åke Levin

Abstract

The aim of this prospective substudy was to estimate the cost-effectiveness of treating paroxysmal atrial fibrillation (AF) with radiofrequency catheter ablation (RFA) compared with antiarrhythmic drugs (AADs) as first-line treatment.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 88 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 14%
Researcher 8 9%
Student > Bachelor 8 9%
Other 7 8%
Student > Postgraduate 6 7%
Other 18 20%
Unknown 29 33%
Readers by discipline Count As %
Medicine and Dentistry 39 44%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Biochemistry, Genetics and Molecular Biology 3 3%
Engineering 2 2%
Economics, Econometrics and Finance 2 2%
Other 7 8%
Unknown 32 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 April 2021.
All research outputs
#3,813,942
of 25,450,869 outputs
Outputs from Europace
#833
of 3,096 outputs
Outputs of similar age
#42,815
of 273,389 outputs
Outputs of similar age from Europace
#6
of 31 outputs
Altmetric has tracked 25,450,869 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,096 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 273,389 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.